Since the beginning of the pandemic, efforts have been focused on developing a vaccine capable of providing immunity against SARS-CoV-2. With multiple vaccine candidates now
In a move with far reaching implications for the debates around pharmaceutical patents, innovation and access to medicines, the Indian patent office issued its first